The AI Scribe Free Trial Trap: What to Actually Test in Two Weeks

Why most free trials don't actually test anything

The free trial of an AI scribe is supposed to be the moment you find out whether it works for your practice. In reality, most trials end with the clinician feeling either vaguely positive ("yeah, it seemed fine") or vaguely negative ("eh, not sure"), with no specific evidence either way.

That happens because the trial period gets used for what's convenient, not for what's diagnostic. You try it on a few easy visits, you don't run into anything dramatic, you let the trial expire, and you make the decision based on the marketing materials anyway. The vendor wins that game; you don't.

This article is the structured two-week plan that turns a free trial into actual data. What to test, in what order, what to record, and how to interpret what you see.

The decision the trial should answer

Before the trial starts, write down on paper what specific decision you're trying to make. The vague version ("is this any good?") leads to vague results. The specific version produces decisions.

Examples of useful specific questions:

• Does this AI scribe accurately capture the medications I prescribe in my typical follow-up visits?
• Does the time savings make a meaningful difference to my evening hours within two weeks?
• Will my patients consent to this at a rate I can live with?
• Does this integrate with my EHR well enough that I'm not doing copy-paste all day?
• Is the output quality good enough that I can trust it without re-reading every word?

Pick two to four of these. Write them at the top of a single sheet of paper. The trial is now about answering those questions, not about general impressions.

Day 1 to 3: baseline calibration

The first three days are not about evaluating the AI. They're about establishing what your baseline is.

Time yourself on documentation BEFORE the trial. For three clinic days before turning on the AI scribe, track how long you spend on documentation per encounter. Use a stopwatch app or just glance at the clock. Most providers underestimate this by 30 to 50 percent. The trial only matters relative to a real baseline.

Record your end-of-day state. Each night for the three baseline days, note what time you finished charting and how you felt. "Finished at 7:45pm, tired, three notes still open" is a useful baseline. "Finished at 5:30pm, relaxed, all notes closed" is a different baseline.

Pick the patient types you'll evaluate against. A solo PCP might pick three categories: typical follow-ups, new patient intakes, and chronic disease management visits. The trial should cover all three categories, not just whichever shows up randomly.

Day 4 to 7: realistic use, careful observation

This is the first real-use week. The goal is not to optimize for impressive results. The goal is to see what the tool does under normal conditions.

Use the AI on every consenting patient. Don't cherry-pick easy visits. The trial only tells you something useful if the visits are representative.

Track specific metrics in a simple log. A spreadsheet or paper log with five columns:

Date	Patient type	AI used?	Time to sign	Notes

The "notes" column captures anything that mattered: a mishear, a particularly good note, a workflow friction. Spend 30 seconds per encounter logging.

At the end of each day, answer one question in writing. "What did the AI do well today and what did it do badly?" One sentence each. Doing this in writing matters because memory blurs across days. The written record is what you'll review at the end of the trial.

Day 8 to 10: stress test

The second week starts with deliberate stress testing. The goal is to find the failure modes.

Test the AI on your most complex visits. The patient with five chronic conditions, the new patient with a complicated history, the visit where you discuss multiple plan changes. Don't avoid these visits during the trial; they're exactly the ones where the AI's accuracy matters most.

Test the AI on a difficult audio environment. A patient with a quiet voice, a heavy accent, or with kids in the room. These are real visits in your practice. They need to be in the evaluation.

Test the AI with a deliberate mid-visit pause. Pause the recording mid-visit, then resume. Test what happens to the note. Some platforms handle this gracefully; some lose context. Knowing which is good to know before you commit.

Test the AI when wifi is shaky. If you have one exam room with marginal wifi, use the AI there during the trial. Better to discover the problem now than after signing.

Day 11 to 14: the workflow test

The last week of the trial is about whether you can actually live with the workflow, not just whether the AI is accurate.

Try to sign every note before the next patient walks in. This is the workflow that gets your evenings back. If you can't do it during the trial (because the AI is too slow, the output is too verbose, the review is too detailed), you won't do it in production either. Test this aggressively.

Try to leave the office at your target time. If your goal is to leave at 5:30pm, try to actually leave at 5:30pm during the second week. Did the AI make this possible? Did it not?

Try the customization features. Adjust a template, add a vocabulary correction, change a default. The platforms differ enormously in how easy customization is, and you only find out by trying.

Talk to your spouse or partner about whether they've noticed any change. This is the most honest data source you have about whether the time savings are translating to life-side benefit.

The questions to answer at the end

By the end of two weeks, you should be able to answer specifically:

Accuracy questions:

• What's the medication misheard rate in your data? (number of misheard medications divided by number of medication-containing visits)
• What's the rate of notes that needed substantial editing vs. minor or no editing?
• Are there specific failure patterns that recur (specific drug names, specific visit types, specific patient demographics)?

Time questions:

• What was the average time-to-sign per encounter compared to your baseline?
• How many notes were signed at point of care vs. after clinic?
• How much did your end-of-day finish time shift?

Workflow questions:

• Did the EHR integration actually work, or did you do copy-paste?
• Were there workflow frictions you couldn't customize away?
• Did your staff have to do additional work because of the trial?

Patient questions:

• What was the consent acceptance rate?
• Did any patients have particularly positive or negative reactions you should weight more heavily?

Subjective questions:

• Did you feel more present with patients?
• Did the cognitive load of clinic days change?
• Would you recommend this tool to a colleague?

The vague "yeah, it was fine" answer dissolves under specific questions. You'll know what you think.

The trial mistakes that ruin the data

A few patterns that produce useless trial results:

Using the AI only for easy visits. "I'll try it on the simple follow-ups first." Then you only have data on simple follow-ups, and you sign a contract based on that data, and your complex visits go badly. Use it on everything.

Not setting up customization during the trial. "I'll wait to customize until I commit." Then you evaluate based on default behavior, which underperforms the customized behavior, and you either reject a tool that would have been good or sign up for the wrong reason. Customize during the trial; that's part of evaluating whether customization is reasonable.

Stopping when the slump hits. The first-two-weeks slump means you'll feel worse at the end of week one than at the end of week two. Don't end the trial when you're in the middle of the slump; either you push through and see the improvement, or you cancel and commit to the conclusion.

Not testing on a problematic patient demographic. If your practice has significant LEP patients, complex Medicare beneficiaries, or other populations that might stress the AI, you need to test there. See AI scribe with limited-English-proficiency patients for that specific case.

Letting the vendor's customer success team drive the trial. They will guide you toward visits and use patterns that show their product well. Their guidance is worth listening to, but their goal is to make the trial successful, which is not exactly the same as your goal of finding out whether the tool works for you. Run the trial on your own terms.

When to extend the trial

Some vendors offer to extend a two-week trial to four or six weeks. This is usually worth taking if:

• You're undecided at the end of week two
• The slump is still in effect at the end of week two
• You haven't tested on a representative sample of visit types
• Customization is still in progress

It's not worth taking if:

• You're decisively against the tool. The extension just delays a decision you've already made.
• You're decisively in favor. The extension delays committing to a tool you know you want.

The middle case is where extensions help.

When the trial reveals a vendor mismatch

Sometimes the trial reveals that the AI scribe is fine but this vendor isn't a fit. Patterns that suggest you should evaluate other vendors:

• The AI's accuracy is in the right range but the EHR integration is poor
• The output is generally good but customization is unsupported
• The tool itself works but customer support has been unresponsive
• The pricing model doesn't fit your practice (per-encounter pricing for a high-volume practice, for example, can be wrong even if the tool is right)

The trial is partly about the AI and partly about the vendor relationship. Both have to work. If one is broken, switching vendors mid-evaluation is a reasonable response.

The decision framework at the end

Two weeks in, you have data. The decision is now structured:

Sign up if: your specific pre-trial questions are answered affirmatively, the accuracy is acceptable for your practice, the workflow saves meaningful time, and you can imagine using the tool a year from now without friction.

Don't sign up if: the accuracy doesn't meet your bar, the workflow can't fit your practice, or the cost doesn't pencil out against the actual time saved (not the time saved as promised).

Extend or try another vendor if: the tool seems promising but the data is incomplete, or this vendor fails on something specific that another vendor might handle.

The structured trial turns a fuzzy adoption decision into a sharp one. The vendor will appreciate the clarity; the right vendor wants you to know exactly what you're getting before you commit.

---

For the ROI math that the trial data feeds into, see the solo practice ROI walkthrough. For what to do once you commit, the first-week onboarding plan covers the production rollout.